skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Myopathy following postoperative ablative radioiodine for follicular carcinoma of the thyroid

Case report

(2961) Views  (835) Full article downloads

Authors: Hermione C Price, Vijay Jayagopal

Published Date March 2009 Volume 2009:2 Pages 11 - 13
DOI: http://dx.doi.org/10.2147/IMCRJ.S5254

Hermione C Price, Vijay Jayagopal

Centre for Diabetes and Endocrinology, York Hospital, York, UK

Abstract: We highlight a case of disabling myopathy following radioablative iodine treatment for follicular carcinoma of the thyroid. A 34-year-old man presented with a tender neck swelling, ultrasound and biopsy were suggestive of thyroid malignancy. Thyroidectomy was undertaken and histology confirmed follicular carcinoma of the thyroid. Treatment with ablative radioiodine followed and within days the patient developed disabling myopathy. Investigations to date do not reveal any other cause for the myopathy and there is no evidence to suggest that this is a paraneoplastic phenomenon. We believe this is the first reported case of ablative radioiodine-induced mypoathy.

Keywords: thyroid neoplasms, muscular diseases, iodine radioisotopes








Readers of this article also read:

Antihypertensive effects of astaxanthin
Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study
Cuff inflation during ambulatory blood pressure monitoring and heart rate
Postoperative pulmonary embolism in a three year old with Klippel–Trenaunay syndrome
A case of endobronchial lipoma mimicking bronchial asthma
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Polyostotic fibrous dysplasia of the ribs: An unusual cause of chest pain and dyspnea
Congestive heart failure in subjects with thyrotoxicosis in a black community
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Role of vandetanib in the management of medullary thyroid cancer